Cover Image

Impact of COVID-19 quarantines on clozapine-induced constipation: Experience of utilizing a clozapine-induced constipation protocol at a state forensic psychiatric facility

Objective Since 2017, Fulton State Hospital (FSH) has implemented a clozapine-induced constipation protocol. In March 2020, FSH initiated unit quarantines to minimize the spread of coronavirus disease (COVID-19). The objective of this study was to evaluate the impact of these quarantines on medical...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bridgette M. Gleisner, PharmD (Author), O. Greg Deardorff, PharmD, BCPP (Author), Yifei Liu, BS Pharm, PhD (Author), Megan G. Trout, PharmD (Author), Joshua R. Wood, PharmD (Author), Roger W. Sommi, PharmD, BCPP, FCCP (Author), Niels C. Beck, PhD (Author)
Format:	Book
Published:	American Association of Psychiatric Pharmacists, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diltiazem for clozapine-induced generalized hyperhidrosis
by: Kenton Emma M. PharmD, et al.
Published: (2023)

Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid
by: Ranel Troy Santos, PharmD, BCPP, et al.
Published: (2023)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021)

Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022)

Evaluation of major adverse events of clozapine based on accordance to an international titration guideline
by: Matthew Nuebel, PharmD, et al.
Published: (2024)

Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024)

A case report on the effects of COVID-19 on ANC monitoring in a patient on long-term clozapine treatment
by: Denton Lauren PharmD, et al.
Published: (2023)

Antipsychotic factors related to time to competency for forensic inpatients in a state psychiatric facility
by: Amber Lemons, PharmD, BCPP, et al.
Published: (2022)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
by: Trevor A. Stump, PharmD, BCPP, et al.
Published: (2021)

Terbinafine and risperidone drug interaction contributing to clinical changes in a forensic psychiatric patient
by: Reynolds Jamie PharmD, et al.
Published: (2023)

Risperidone-induced angioedema
by: Caitlin Burton, PharmD, BCPP, et al.
Published: (2024)

Barriers to access to psychiatric medications in Missouri county jails
by: Burval Jessica K. PharmD, BCPP, et al.
Published: (2023)

Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021)

Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects
by: Dayton L. Antley, PharmD, BCPS, BCPP, et al.
Published: (2023)

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024)

Pharmacologic management of adolescent catatonia: A dual-case series
by: Lauren Leiby, PharmD, BCPP, et al.
Published: (2024)

Comment on "An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use"
by: Still Daniel PharmD, BCPP, et al.
Published: (2023)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023)

COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
by: Brianna Englett, PharmD, BCPP, et al.
Published: (2021)

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022)

Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events
by: Monica Barrett, PharmD, BCPP, et al.
Published: (2024)

"It's been a long time since I drank like that": A case report of binge drinking associated with aripiprazole
by: Alyssa Falleni, PharmD, et al.
Published: (2024)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023)

Assessing the understandability, actionability, and quality of online resources for the self-management of bipolar disorder
by: Nathan D. Sutera, PharmD, et al.
Published: (2022)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022)

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
by: Danielle Dauchot, PharmD, et al.
Published: (2024)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023)

Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers
by: Carrillo Nina PharmD, et al.
Published: (2023)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022)

Severe olanzapine-induced liver function test elevation
by: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, et al.
Published: (2023)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024)

Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022)

Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
by: Becky S. Linn PharmD, et al.
Published: (2021)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024)

Stewardship applied to antipsychotics: Development of an antipsychotic stewardship program in inpatient settings for monitoring and optimizing outcomes
by: Gillian Gonzales, PharmD, et al.
Published: (2022)